Cubist Systematic Strategies, LLC Horizon Therapeutics Public LTD CO Transaction History

Cubist Systematic Strategies, LLC

$17.3 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $3.84 Million - $7 Million	-61,529 Reduced 62.97%	36,181 $4.12 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $491,333 - $706,063	-8,339 Reduced 7.86%	97,710 $6.05 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $1.31 Million - $1.92 Million	16,513 Added 18.44%	106,049 $8.46 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $794,891 - $1.01 Million	9,198 Added 11.45%	89,536 $9.42 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $1.11 Million - $1.35 Million	11,262 Added 16.3%	80,338 $8.66 Million

Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $5.16 Million - $6.2 Million	56,179 Added 435.6%	69,076 $7.57 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $15,868 - $17,649	184 Added 1.45%	12,897 $1.21 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $913,174 - $1.21 Million	12,713 New	12,713 $1.17 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $11.6 Million - $14.6 Million	-173,262 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $7.64 Million - $11.1 Million	138,305 Added 395.64%	173,262 $13.5 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $114,760 - $216,524	-3,800 Reduced 9.8%	34,957 $1.94 Million
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $670,420 - $1.04 Million	26,957 Added 228.45%	38,757 $1.15 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $2.02 Million - $2.91 Million	-79,280 Reduced 87.04%	11,800 $427,000
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $2.92 Million - $3.55 Million	-127,049 Reduced 58.24%	91,080 $2.48 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $4.98 Million - $6.21 Million	218,129 New	218,129 $5.25 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account